Records containing: Mesotheliomas Pleural
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-07-13A Phase 1/2 Single Arm Open-Label Clinical Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
-
CLINICAL_TRIALS study record update · 2026-02-17A Pilot Study of Partial Pleurectomy in Borderline and Unresectable Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2025-12-04Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
-
CLINICAL_TRIALS study record update · 2025-09-25Intrapleural Photodynamic Therapy by Video-Assisted Thoracoscopy Followed by Anti-PD-1 NIVOLUMAB in Patients With Malignant Pleural Mesothelioma - a Pilot Study
-
CLINICAL_TRIALS study record update · 2025-09-05From Immune Microenvironment Characterization and Gene Expression Profiling to New Drugs Testing in Pleural and Peritoneal Mesothelioma: Imaging-Meso Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-08-27A Phase 1/2 Single Arm Open-Label Clinical Trial of Gavocabtagene Autoleucel (Gavo-cel) in Patients With Advanced Mesothelin-Expressing Cancer
-
CLINICAL_TRIALS study record update · 2025-08-27A Phase 1/2 Single Arm Open-Label Clinical Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
-
CLINICAL_TRIALS study record update · 2025-07-15Phase 2 Study of Sacituzumab Govitecan-hziy in Patients With Previously Treated Mesothelioma
-
CLINICAL_TRIALS study record update · 2025-06-05A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma
-
CLINICAL_TRIALS study record update · 2025-04-29Phase I Study of Human Chimeric Antigen Receptor Modified T Cells in Patients With Mesothelin Expressing Cancers
-
CLINICAL_TRIALS study record update · 2025-04-25Phase I, Open-Label Study With Dendritic Cell Therapy (MesoPher) In Combination With Ex-tended-Pleurectomy/Decortication After Chemotherapy in Subjects With Resectable Mesothelioma
-
CLINICAL_TRIALS study record update · 2025-03-13PHASE III STUDY WITH ATEZOLIZUMAB VERSUS PLACEBO IN MALIGNANT PLEURAL MESOTHELIOMA PATIENTS AFTER PLEURECTOMY/DECORTICATION
-
CLINICAL_TRIALS study record update · 2024-12-24A Phase 1B/2A Study of the Safety, Tolerability and Initial Efficacy of Oral AMXT 1501 Dicaprate and Intravenous Difluoromethylornithine (DFMO) in Patients With Cancer
-
CLINICAL_TRIALS study record update · 2024-11-05PEMbrolizumab Plus Lenvatinib In Second Line And Third Line Malignant Pleural MEsotheLiomA Patients(PEMMELA)
-
CLINICAL_TRIALS study record update · 2024-06-11Prognostic Significance of Ga-68 FAPI PET Before Immunotherapy in Pleural Mesothelioma
-
CLINICAL_TRIALS study record update · 2024-02-29Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma (the NIPU-study)
-
CLINICAL_TRIALS study record update · 2024-01-26A Translational Phase 1/2 Dose-Escalation and Expansion Study to Determine Safety, Tolerability, and Recommended Phase 2 Dose of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
-
CLINICAL_TRIALS study record update · 2023-03-03A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors